Navigation Links
CPhI India and Co-Located Events Offer Diverse Programme to Support the Growing Indian Pharma Market
Date:10/18/2011

AMSTERDAM, Oct. 18, 2011 /PRNewswire/ -- Leading events organiser UBM Live, a division of UBM Plc (LSE: UBM), today announced details of CPhI India and its co-located events, which will be hosted from 30th November to 2nd December, 2011 at the Bombay Exhibition Centre in Mumbai, India. Focused on pharmaceutical ingredients, CPhI India will be joined by co-located events: P-MEC India for pharmaceutical equipment, machinery and technology; ICSE India for contract services, clinical trials; and CRO and the BioPh trail for the biopharma market. Catering to all sectors in the pharma industry, both domestic and international, UBM Live's cluster of India-focused events offer attendees a dedicated platform to network with key decision makers in the Indian pharmaceutical industry, connect with existing  partners and make new contacts. In 2010 the events hosted over 26,400 visitors and over 800 exhibiting companies, figures that UBM Live expects to be exceed this year.

Continuing UBM Live's commitment to developing and evolving value-add initiatives for visitors and exhibitors around its Indian events, the CPhI India Conference Series will return in 2011. Introduced in 2010 to positive feedback, the series programme will cover a selection of key trends and topics pertinent to the Indian and South Asian pharmaceuticals markets, including: Global Clinical Trials; Global Biosimilars Regulations; Healthcare and OTC Drugs; Developing Difficult Generics; Export Potential; and Competitive API Strategies.  The conference series will feature high level speakers from respected companies such as Sanofi-Aventis, GlaxoSmithKline, Pfizer, and Dr. Reddy's Laboratories.

"Mirroring the increasing importance of the Indian pharmaceutical market, CPhI India and co-located events have been built around a unique programme based on consultation and feedback from visitors and exhibitors," commented Annemieke Timmers, Brand Director CPhI. "We have geared the show to deliver significant return on investment (ROI) for pharma professionals who are currently working with or looking to establish relationships with Indian pharmaceutical companies.  Our events offer direct access to a high-growth market that is estimated to generate US $13.1 Billion revenue in FY 2011(1). Beyond the immediate projections for the market, the domestic pharmaceutical industry in India is expected to further grow at a compounded annual growth rate (CAGR) of around 15% during FY 2012-FY 2014(2).  Our visitors are guaranteed to benefit from strengthening current business relations and making new business connections in a market that is well equipped to scale-up to requests for products and services quickly through networks that take advantage of the latest technologies available."

CPhI India and P-MEC India are the largest and most comprehensive pharma industry events in South Asia and have gained a reputation as the 'must attend' events in this market. Additionally, ICSE India has quickly gained a positive reputation in the market by offering direct access to the outsourcing and contract services sector which is one of the fastest growing segments within the Indian pharmaceutical industry, and weekly pre-registrations are currently running over 300% higher than they were at the same time in 2010.

UBM Live's market leading annual schedule of pharma brands includes CPhI for pharmaceutical ingredients, ICSE for contract services and outsourcing, P-MEC Europe for pharmaceutical equipment, machinery and technology, InnoPack for innovative packaging concepts in the pharmaceutical packaging market, and BioPh for the biopharmaceuticals market. Co-located annual events include Worldwide (25-27, October, Messe Frankfurt, Germany 2011), Japan (21-23 March, 2012, Tokyo Big Sight Exhibition Center, Japan) China (26-28 June, 2012, SNIEC, Shanghai, China), and South America (21-23 August, 2012, Transamerica Expo Centre, Brazil).

(1) RNCOS, India Pharma Sector Forecast 2014

(2) RNCOS, India Pharma Industry Set to Take Off in Near Future

Notes for Editors:

UBM Live is a division of UBM Plc (LSE: UBM) a leading provider of business information services to the maritime, travel, fashion, technology, healthcare, media, and property industries. UBM offers services in trade shows, online, news distribution, and publishing to customers across the globe. Its brands are represented in more than 30 countries and are organized into specialist teams that serve their business communities helping them excel in their market by working effectively and efficiently. For more information, go to www.ubmlive.com.


'/>"/>
SOURCE UBM Live
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
2. Kibow Biotech Obtains Australian, Chinese and Indian Patents Protecting the Composition and Basic Technology Behind Its Oral Probiotic Formulation for Chronic Kidney Failure
3. Neutropenia: Biosimilar Product from India Moves One Step Closer to European Market
4. ImQuest Scientists Present Important HIV Microbicide Development Results at Microbicides 2008 in Delhi, India
5. International Diabetes Federation Grant Supports Lifestyle Intervention Study to Prevent Type 2 Diabetes in India
6. Immigrants From India, Pakistan Face U.S. Prostate, Breast Cancer Risks
7. Patient Recruitment Begins in India for Phase 3 Diabetes Trial
8. Report on 300 New Medicines in Development for Heart Disease and Stroke Released in Indianapolis
9. Life Sciences Company Opens Clinical Trial Bridge to India
10. Pioneering Brain Malformation Treatment Performed Using Novalis Tx(TM) Radiosurgery Technology in India
11. Reportlinker Adds Medical Devices & Equipment in India (2009)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... CLEVELAND , Jan. 19, 2017 ViewRay, ... (DFG), a federal institution supporting research in ... installation and patient treatments at the University Clinic Heidelberg ... The MRIdian Linac program will be headed ... who also heads radiation oncology at the German Cancer ...
(Date:1/19/2017)... Calif. , Jan. 19, 2017   Science ... is excited to announce that the first five ... Biology  (RP:CB) have been published in eLife today. ... project represents the first practical evaluation of reproducibility ... in reproducible studies. Unlike other assessments of reproducibility, ...
(Date:1/19/2017)... -- New Review of Safinamide - ... and Motor Complications in Mid- to Late-stage Parkinson,s ... ... C Warren Olanow , ... 2-15, http://www.touchneurology.com/articles/safinamide-new-therapeutic-option-address-motor-symptoms-and-motor-complications-mid-late Published recently ...
Breaking Medicine Technology:
(Date:1/19/2017)... ... January 19, 2017 , ... Bill Howe Plumbing, Heating ... the American Heart Association; “Howe” Healthy is Your Heart Drawing Contest The ... active. Each year, Bill Howe Plumbing, Heating & Air receives over 600 entries. The ...
(Date:1/19/2017)... Marriottsville, MD (PRWEB) , ... January 19, 2017 , ... ... launched six new clients into the US market. , Over the past 20 years ... the past 4 weeks SFI has launched six new clients into the US market. ...
(Date:1/19/2017)... Georgia (PRWEB) , ... January 19, 2017 , ... ... Surgeons hosts the Atlanta Breast Surgery Symposium, a conference where hundreds of surgeons ... advancements in breast surgery. Covering topics from cosmetic breast augmentation to ...
(Date:1/18/2017)... ... 2017 , ... A recent video posting of a new fidget product gathered ... fidgeting to relieve stress and anxiety. No one was more surprised than Think ... just completed a successful Kickstarter campaign raising $67,000 on the popular crowdfunding platform. ...
(Date:1/18/2017)... (PRWEB) , ... January 18, 2017 , ... ... manage it from the number one doctor-recommended OTC antiperspirant, Certain Dri. , Excessive ... go untreated. , Certain Dri created this infographic to explain the seven types ...
Breaking Medicine News(10 mins):